Literature DB >> 16794286

Rubella outbreak in an unvaccinated religious community in the Netherlands leads to cases of congenital rubella syndrome.

Ytje van der Veen1, Susan Hahné, Helma Ruijs, Rob van Binnendijk, Aura Timen, A M van Loon, Hester de Melker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16794286     DOI： 10.2807/esw.10.47.02839-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


× No keyword cloud information.
  5 in total

1.  Intervening to reduce inequalities in infections in Europe.

Authors:  Jan C Semenza; Johan Giesecke
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

2.  Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets.

Authors:  Anthony Nardone; Annedore Tischer; Nick Andrews; Jo Backhouse; Heidi Theeten; Nina Gatcheva; Marios Zarvou; Bohumir Kriz; Richard G Pebody; Kalman Bartha; Darina O'Flanagan; Dani Cohen; Arnis Duks; Algirdas Griskevicius; Joel Mossong; Christopher Barbara; Adrianna Pistol; Margareta Slaciková; Katarina Prosenc; Kari Johansen; Elizabeth Miller
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

3.  Rubella outbreak in a Rural Kenyan District, 2014: documenting the need for routine rubella immunization in Kenya.

Authors:  Ian Njeru; Dickens Onyango; Yusuf Ajack; Elizabeth Kiptoo
Journal:  BMC Infect Dis       Date:  2015-06-27       Impact factor: 3.090

4.  Balancing evidence and uncertainty when considering rubella vaccine introduction.

Authors:  Justin Lessler; C Jessica E Metcalf
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

Review 5.  Under-vaccinated groups in Europe and their beliefs, attitudes and reasons for non-vaccination; two systematic reviews.

Authors:  N Fournet; L Mollema; W L Ruijs; I A Harmsen; F Keck; J Y Durand; M P Cunha; M Wamsiedel; R Reis; J French; E G Smit; A Kitching; J E van Steenbergen
Journal:  BMC Public Health       Date:  2018-01-30       Impact factor: 3.295
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.